Report Detail
Global Puerarin for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4591727 |
- 21 May, 2024 |
- Global |
- 105 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Puerarin for Injection is a pharmaceutical product derived from the root of the kudzu plant (Pueraria lobata), traditionally used in Chinese medicine. Puerarin contains bioactive compounds such as isoflavones, particularly puerarin, known for its antioxidant, vasodilatory, and neuroprotective properties. This injectable form of puerarin is used in the treatment of cardiovascular diseases, including coronary artery disease, hypertension, and angina pectoris. It improves blood flow, reduces oxidative stress, and enhances cardiac function, making it beneficial for patients with cardiovascular conditions. Puerarin injections are administered in hospitals and clinics as an adjunct therapy for managing cardiovascular risk factors and preventing cardiovascular events.
According to our (Global Info Research) latest study, the global Puerarin for Injection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
The industry trend for Puerarin for Injection reflects a growing interest in natural remedies and botanical medicines for cardiovascular health and disease prevention. With a shift towards holistic approaches to healthcare, there's increasing demand for plant-derived therapeutics like puerarin that offer cardiovascular benefits with potentially fewer side effects compared to conventional medications. Pharmaceutical companies are investing in research and development to explore the pharmacological properties and therapeutic applications of puerarin and its derivatives in cardiovascular medicine. Additionally, there's a focus on developing standardized formulations and quality control measures to ensure the safety, efficacy, and reproducibility of puerarin injections, driving their integration into evidence-based treatment protocols for cardiovascular diseases.
This report is a detailed and comprehensive analysis for global Puerarin for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Puerarin for Injection market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Puerarin for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Puerarin for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Puerarin for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Puerarin for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Puerarin for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Procurenet, Actiza Pharmaceutical, Chengdu Tiantai Mountain Pharmaceutical, You Care, Harbin Sanlian Pharmaceutical, Beijing Sihuan Kebao Pharmaceutical, Hubei Tianyao Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Puerarin for Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.1g
0.2g
Others
Market segment by Application
Hospital
Clinic
Major players covered
Procurenet
Actiza Pharmaceutical
Chengdu Tiantai Mountain Pharmaceutical
You Care
Harbin Sanlian Pharmaceutical
Beijing Sihuan Kebao Pharmaceutical
Hubei Tianyao Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Puerarin for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Puerarin for Injection, with price, sales quantity, revenue, and global market share of Puerarin for Injection from 2019 to 2024.
Chapter 3, the Puerarin for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Puerarin for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Puerarin for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Puerarin for Injection.
Chapter 14 and 15, to describe Puerarin for Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Puerarin for Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 0.1g
- 1.3.3 0.2g
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Puerarin for Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Puerarin for Injection Market Size & Forecast
- 1.5.1 Global Puerarin for Injection Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Puerarin for Injection Sales Quantity (2019-2030)
- 1.5.3 Global Puerarin for Injection Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Procurenet
- 2.1.1 Procurenet Details
- 2.1.2 Procurenet Major Business
- 2.1.3 Procurenet Puerarin for Injection Product and Services
- 2.1.4 Procurenet Puerarin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Procurenet Recent Developments/Updates
- 2.2 Actiza Pharmaceutical
- 2.2.1 Actiza Pharmaceutical Details
- 2.2.2 Actiza Pharmaceutical Major Business
- 2.2.3 Actiza Pharmaceutical Puerarin for Injection Product and Services
- 2.2.4 Actiza Pharmaceutical Puerarin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Actiza Pharmaceutical Recent Developments/Updates
- 2.3 Chengdu Tiantai Mountain Pharmaceutical
- 2.3.1 Chengdu Tiantai Mountain Pharmaceutical Details
- 2.3.2 Chengdu Tiantai Mountain Pharmaceutical Major Business
- 2.3.3 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Product and Services
- 2.3.4 Chengdu Tiantai Mountain Pharmaceutical Puerarin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Chengdu Tiantai Mountain Pharmaceutical Recent Developments/Updates
- 2.4 You Care
- 2.4.1 You Care Details
- 2.4.2 You Care Major Business
- 2.4.3 You Care Puerarin for Injection Product and Services
- 2.4.4 You Care Puerarin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 You Care Recent Developments/Updates
- 2.5 Harbin Sanlian Pharmaceutical
- 2.5.1 Harbin Sanlian Pharmaceutical Details
- 2.5.2 Harbin Sanlian Pharmaceutical Major Business
- 2.5.3 Harbin Sanlian Pharmaceutical Puerarin for Injection Product and Services
- 2.5.4 Harbin Sanlian Pharmaceutical Puerarin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Harbin Sanlian Pharmaceutical Recent Developments/Updates
- 2.6 Beijing Sihuan Kebao Pharmaceutical
- 2.6.1 Beijing Sihuan Kebao Pharmaceutical Details
- 2.6.2 Beijing Sihuan Kebao Pharmaceutical Major Business
- 2.6.3 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Product and Services
- 2.6.4 Beijing Sihuan Kebao Pharmaceutical Puerarin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Beijing Sihuan Kebao Pharmaceutical Recent Developments/Updates
- 2.7 Hubei Tianyao Pharmaceutical
- 2.7.1 Hubei Tianyao Pharmaceutical Details
- 2.7.2 Hubei Tianyao Pharmaceutical Major Business
- 2.7.3 Hubei Tianyao Pharmaceutical Puerarin for Injection Product and Services
- 2.7.4 Hubei Tianyao Pharmaceutical Puerarin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Hubei Tianyao Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Puerarin for Injection by Manufacturer
- 3.1 Global Puerarin for Injection Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Puerarin for Injection Revenue by Manufacturer (2019-2024)
- 3.3 Global Puerarin for Injection Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Puerarin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Puerarin for Injection Manufacturer Market Share in 2023
- 3.4.3 Top 6 Puerarin for Injection Manufacturer Market Share in 2023
- 3.5 Puerarin for Injection Market: Overall Company Footprint Analysis
- 3.5.1 Puerarin for Injection Market: Region Footprint
- 3.5.2 Puerarin for Injection Market: Company Product Type Footprint
- 3.5.3 Puerarin for Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Puerarin for Injection Market Size by Region
- 4.1.1 Global Puerarin for Injection Sales Quantity by Region (2019-2030)
- 4.1.2 Global Puerarin for Injection Consumption Value by Region (2019-2030)
- 4.1.3 Global Puerarin for Injection Average Price by Region (2019-2030)
- 4.2 North America Puerarin for Injection Consumption Value (2019-2030)
- 4.3 Europe Puerarin for Injection Consumption Value (2019-2030)
- 4.4 Asia-Pacific Puerarin for Injection Consumption Value (2019-2030)
- 4.5 South America Puerarin for Injection Consumption Value (2019-2030)
- 4.6 Middle East & Africa Puerarin for Injection Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Puerarin for Injection Sales Quantity by Type (2019-2030)
- 5.2 Global Puerarin for Injection Consumption Value by Type (2019-2030)
- 5.3 Global Puerarin for Injection Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Puerarin for Injection Sales Quantity by Application (2019-2030)
- 6.2 Global Puerarin for Injection Consumption Value by Application (2019-2030)
- 6.3 Global Puerarin for Injection Average Price by Application (2019-2030)
7 North America
- 7.1 North America Puerarin for Injection Sales Quantity by Type (2019-2030)
- 7.2 North America Puerarin for Injection Sales Quantity by Application (2019-2030)
- 7.3 North America Puerarin for Injection Market Size by Country
- 7.3.1 North America Puerarin for Injection Sales Quantity by Country (2019-2030)
- 7.3.2 North America Puerarin for Injection Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Puerarin for Injection Sales Quantity by Type (2019-2030)
- 8.2 Europe Puerarin for Injection Sales Quantity by Application (2019-2030)
- 8.3 Europe Puerarin for Injection Market Size by Country
- 8.3.1 Europe Puerarin for Injection Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Puerarin for Injection Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Puerarin for Injection Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Puerarin for Injection Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Puerarin for Injection Market Size by Region
- 9.3.1 Asia-Pacific Puerarin for Injection Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Puerarin for Injection Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Puerarin for Injection Sales Quantity by Type (2019-2030)
- 10.2 South America Puerarin for Injection Sales Quantity by Application (2019-2030)
- 10.3 South America Puerarin for Injection Market Size by Country
- 10.3.1 South America Puerarin for Injection Sales Quantity by Country (2019-2030)
- 10.3.2 South America Puerarin for Injection Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Puerarin for Injection Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Puerarin for Injection Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Puerarin for Injection Market Size by Country
- 11.3.1 Middle East & Africa Puerarin for Injection Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Puerarin for Injection Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Puerarin for Injection Market Drivers
- 12.2 Puerarin for Injection Market Restraints
- 12.3 Puerarin for Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Puerarin for Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Puerarin for Injection
- 13.3 Puerarin for Injection Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Puerarin for Injection Typical Distributors
- 14.3 Puerarin for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Puerarin for Injection. Industry analysis & Market Report on Puerarin for Injection is a syndicated market report, published as Global Puerarin for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Puerarin for Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
